Yan Zhong-Yi, Luo Zhi-Qing, Zhang Lai-Jian, Li Jia, Liu Jia-Qiang
Department of Stomatology, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu, China.
Department of Stomatology, The Affiliated Huai'an Hospital of Xuzhou Medical University and The Second People's Hospital of Huai'an, Huai'an, China.
J Cell Physiol. 2017 Aug;232(8):2178-2185. doi: 10.1002/jcp.25728. Epub 2017 Mar 1.
MicroRNAs have been used as diagnostic and prognostic biomarkers for many cancers including oral squamous cell carcinoma (OSCC). Several studies have been shown that microRNA (miRNA) play important roles during the progression of OSCC. However, the results vary largely in different studies due to different platforms and sample sizes. In this study, we systematically evaluated a large scale of miRNA profiles from current qualified OSCC samples, and further investigated the functions of genes regulated by these key miRNAs as well as the signaling pathways through which these miRNA effect carcinogenesis. Seven key miRNAs were identified, and of which three were significantly upregulated, including hsa-miR-21, hsa-miR-31, hsa-miR-338, and four were downregulated, namely hsa-miR-125b, hsa-miR-133a, hsa-miR-133b, and hsa-miR-139. The function enrichment analysis revealed that target genes of upregulated miRNAs were associated with cellular protein metabolic process, macromolecule metabolic process, and TGF-beta pathway, while the targets of downregulated were enriched in negative regulation of macromolecule biosynthetic process and gene expression, and p53, long-term potentiation and adherens junction pathways. Transcription factor analysis revealed that there were 67 (51.1%) transcription factors influenced by both up and downregulated miRNAs. In summary, seven key miRNAs were found to play essential role in progression of OSCC, as well as the target genes and transcription factors of these miRNAs. The potential functions of these target genes identified in our study may be profitable to diagnosis and prognostic prediction of OSCC as biomarkers. J. Cell. Physiol. 232: 2178-2185, 2017. © 2016 Wiley Periodicals, Inc.
微小RNA已被用作包括口腔鳞状细胞癌(OSCC)在内的多种癌症的诊断和预后生物标志物。多项研究表明,微小RNA(miRNA)在OSCC进展过程中发挥重要作用。然而,由于平台和样本量不同,不同研究的结果差异很大。在本研究中,我们系统评估了当前合格的OSCC样本的大规模miRNA谱,并进一步研究了这些关键miRNA调控的基因功能以及这些miRNA影响致癌作用的信号通路。鉴定出七个关键miRNA,其中三个显著上调,包括hsa-miR-21、hsa-miR-31、hsa-miR-338,四个下调,即hsa-miR-125b、hsa-miR-133a、hsa-miR-133b和hsa-miR-139。功能富集分析表明,上调miRNA的靶基因与细胞蛋白质代谢过程、大分子代谢过程和TGF-β通路相关,而下调miRNA的靶基因则富集于大分子生物合成过程和基因表达的负调控以及p53、长时程增强和黏附连接通路。转录因子分析显示,有67个(51.1%)转录因子受上调和下调miRNA的共同影响。总之,发现七个关键miRNA在OSCC进展中起重要作用,以及这些miRNA的靶基因和转录因子。我们研究中鉴定出的这些靶基因的潜在功能可能有助于作为生物标志物对OSCC进行诊断和预后预测。《细胞生理学杂志》232: 2178 - 2185, 2017。© 2016威利期刊公司